Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Lymphoma of the Central Nervous System”

110 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 110 results

Testing effectiveness (Phase 2)UnknownNCT04831658
What this trial is testing

A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Mingzhi Zhang 40
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Ended earlyNCT00517699
What this trial is testing

MabThera (Rituximab) in Primary Central Nervous System Lymphoma.

Who this might be right for
Lymphoma
Hoffmann-La Roche 5
Not applicableLooking for participantsNCT07191431
What this trial is testing

A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma（SELINA）

Who this might be right for
Lymphoma Cns
Ruijin Hospital 25
Early research (Phase 1)Study completedNCT01460134
What this trial is testing

CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Who this might be right for
CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more
Celldex Therapeutics 90
Early research (Phase 1)Study completedNCT00916630
What this trial is testing

Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed)

Who this might be right for
Central Nervous System Lymphoma
Massachusetts General Hospital 18
Testing effectiveness (Phase 2)Study completedNCT00006264
What this trial is testing

Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma
AIDS Malignancy Consortium
Testing effectiveness (Phase 2)Looking for participantsNCT04737889
What this trial is testing

Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Henan Cancer Hospital 30
Early research (Phase 1)Study completedNCT00003368
What this trial is testing

Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT07015242
What this trial is testing

The Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 65
Not applicableLooking for participantsNCT06445257
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of ZRMT Regimen in the Treatment of PCNSL

Who this might be right for
Primary Central Nervous System Lymphoma
Huai'an First People's Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267
What this trial is testing

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Who this might be right for
Breast CancerCholangiocarcinomaColorectal Cancer+13 more
Hoffmann-La Roche 534
Early research (Phase 1)Study completedNCT01421524
What this trial is testing

Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma, Large B-Cell, DiffusePleiotropic Pathway Modifier+3 more
Celgene 271
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00237627
What this trial is testing

Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

Who this might be right for
Breast CancerLeukemiaLymphoma+3 more
UNC Lineberger Comprehensive Cancer Center 107
Not applicableStudy completedNCT00103038
What this trial is testing

Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases

Who this might be right for
Central Nervous System LymphomaMalignant GliomaMetastatic Malignant Neoplasm in the Brain
OHSU Knight Cancer Institute 155
Testing effectiveness (Phase 2)Looking for participantsNCT05931328
What this trial is testing

The Study of the Combination of Thiotepa and Pomalidomide for the Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma Patients.

Who this might be right for
Relapsed or Refractory (R/R) Primary Central Nervous System Lymphoma
The First Affiliated Hospital with Nanjing Medical University 28
Testing effectiveness (Phase 2)Study completedNCT00553943
What this trial is testing

Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-cell Lymphoma With Neuromeningeal Invasion at Diagnosis

Who this might be right for
Lymphoma, Non-HodgkinDiffuse Large B-cell Lymphoma
Lymphoma Study Association 60
Large-scale testing (Phase 3)Study completedNCT00006348
What this trial is testing

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Alliance for Clinical Trials in Oncology 100
Testing effectiveness (Phase 2)Looking for participantsNCT05681195
What this trial is testing

Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

Who this might be right for
Primary Central Nervous System LymphomaSecondary Central Nervous System LymphomaRelapsed Cancer+1 more
Baptist Health South Florida 15
Load More Results